United States
US 12,702,687 B2
Pharmaceutical composition for preventing or treating cholestatic liver injury comprising Leuconostoc citreum strain as active ingredient
US 12,702,687 B2 is a granted patent from the United States Patent and Trademark Office (USPTO), dated 2026-08-11. Applicant: LISCure Bio Inc. Its PDF downloads from this page without an account, up to 5 a day.
- Applicant
- LISCure Bio Inc.
- Inventors
- Hwa Sup CHIN
- Publication date
- 2026-08-11
- Filing date
- 2023-08-07
- Document type
- B2 Granted patent
- Also written as
- US 12,702,687 B2 · US12702687 · 12702687
Abstract
The present invention relates to a composition comprising a Leuconostoc citreum strain or its culture as an active ingredient for preventing, improving or treating cholestatic liver injury, specifically primary biliary cirrhosis (PBC) and primary sclerosing cholangitis (PSC). According to the present invention, since the composition exhibits excellent preventive and therapeutic effects on various cholestatic liver injuries, the composition can be usefully used as a composition for the treatment, prevention, improvement, or the like of cholestatic liver injury in humans or animals.
The opening of the abstract. The full text is in the PDF.
No account needed: 5 free downloads a day (5 left today). Batch downloads and Office Action citations need a free account.
Patent office website: United States Patent and Trademark Office (USPTO)
Look up another patent
Need many patents at once?
Paste a whole list of numbers. DownloadPatent finds the right version of each and packs the PDFs into one ZIP.
Sign up free